PAHC as of Nov 2 · 10:52 ET
PAHCNasdaqPharmaceutical Preparations
Phibro Animal Health Corp · Brief
Next report
2 days
Nov 4 · after closeest.Q1 FY27
Expected move
No implied move.
4 of 8≥ implied
- avg implied
- ±13.3%
- avg realized
- ±12.4%
Nov 6 '24±14.3%▲+1.78%×0.12
Feb 5 '25±21.1%▲+9.88%×0.47
May 7 '25±10.8%▲+14.75%×1.36
Aug 27 '25±10.3%▲+19.44%×1.89
Nov 5 '25±13.4%▲+4.59%×0.34
Q2 FY26±10.1%▲+21.95%×2.17
Q3 FY26±12.0%▼−26.22%×2.19
Q4 FY26±14.0%▲+0.72%×0.05
quarterimplied−30%0+30%realized×
Q4 FY26±14.0%▲+0.72%×0.05
Q3 FY26±12.0%▼−26.22%×2.19
Q2 FY26±10.1%▲+21.95%×2.17
Nov '25±13.4%▲+4.59%×0.34
Aug '25±10.3%▲+19.44%×1.89
May '25±10.8%▲+14.75%×1.36
2 older reports
Feb '25±21.1%▲+9.88%×0.47
Nov '24±14.3%▲+1.78%×0.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2 of 3
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
PAHC report sessionSuppliers 1
× = co-movement · max 499dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.